The global biopharmaceutical industry entered 2026 facing one of the largest waves of patent expirations in its history. The potential...

At the time the Commission published its “Proposal for a regulation to simplify rules on medical and in vitro diagnostic devices”, making...

We wrote recently about the European Commission’s proposals to simplify the EU Medical Device Regulation (“MDR”)[1] and EU In Vitro...

There is so much legislative change in the EU and UK in the life sciences sector at the moment that it is sometimes difficult to keep up...

Those working in the Femtech space have a difficult regulatory framework to navigate in the EU. For products that qualify as a medical...

After years in the making, the much-awaited political agreement reached by the EU institutions on the so-called “EU pharma package” will...

The European Commission has published its long-awaited proposal for a regulation to simplify the EU Medical Devices Regulation (“EU...

The European Commission has recently published a draft implementing regulation under the EU Medical Devices Regulations (“EU MDR”)[1] and...

In this third, and final, article of our three-part series - Thinking early: key legal points for early-stage biotech companies - we are...

In this second article of our three-part series - Thinking early: key legal points for early-stage biotech companies - we cover the...

The FemTech sector, which focuses on technology for women’s health and wellness, is experiencing rapid growth in the UK. Out of the 540...

Louisa Jacobs and Oliver Alsop attended this year’s One Nucleus Genesis conference, which brought together industry, investors,...